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OBJECTIVE—The retinoblastoma protein family (pRb, p130,
p107) plays a central role in the regulation of cell cycle progres-
sion. Surprisingly, loss of pRb in the -cell has no discernible
effect on cell cycle control. Therefore, we explored the effects of
individual loss of either p130 or p107 in addition to the simulta-
neous loss of both pRb/p130 on the -cell.
RESEARCH DESIGN AND METHODS—Adult mice deﬁcient
in either p130 or p107 or both pRb/p130 were examined for
effects on -cell replication, function, and survival. The Cre-Lox
system was also used to inactivate pRb in wild-type and p130-
deﬁcient -cells in vitro.
RESULTS—In vivo loss of either p107 or p130 did not affect
-cell replication or function. Combined pRb/p130 loss, however,
resulted in dramatically accelerated proliferation as well as
apoptotic cell death. Pancreas and -cell mass were signiﬁcantly
reduced in double mutants. Despite this, overall glucose toler-
ance was normal, except for mild postprandial hyperglycemia.
Ex vivo, acute deletion of pRb in p130-deﬁcient -cells also
caused a striking increase in proliferation. The combined dele-
tion of pRb/p130 upregulated islet expression of E2F2 but not
E2F1.
CONCLUSIONS—These studies deﬁne an essential role for the
pocket proteins in controlling the G1/S transition in -cells. When
deﬁcient in both pRb and p130, -cells undergo unrestrained cell
cycle reentry and activation of apoptosis. These studies under-
score the central role of the pRb pathway in controlling -cell
turnover and provide new cellular targets for -cell regeneration.
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T
he pocket protein family consists of three mem-
bers, the retinoblastoma tumor suppressor pro-
tein (pRb), p107, and p130. These proteins are
believed to comprise the central regulatory
checkpoint that controls the mammalian G1/S-phase cell
cycle transition. In the absence of pocket proteins, mouse
embryonic ﬁbroblasts are insensitive to G1 arrest signals
and do not undergo senescence in culture (1,2). In the
nonphosphorylated active state, pocket proteins interact
with E2F transcription factors and inhibit E2F-responsive
genes, which are required for cell cycle progression. This
inhibition is relieved when cyclin-dependent kinases phos-
phorylate pocket proteins, altering their conformation,
liberating E2Fs, and thereby permitting passage through
the G1/S checkpoint (3).
p130 and p107 were identiﬁed approximately a decade
after pRb as homologous proteins that play critical roles in
the regulation of cell proliferation (4–8). Common to all
three pocket proteins is the ‘pocket’ domain that interacts
with the E2Fs as well as with viral oncoproteins and the
ability to induce growth arrest when overexpressed
(1,5,9). In addition, all three can repress E2F-mediated
gene transcription, recruit chromatin remodeling enzymes,
and undergo phosphorylation by cyclin-dependent kinases
(9,10). Despite these similarities, there exist extensive
dissimilarities, both structural and functional, among the
three members. For example, p130 and p107 transcription-
ally regulate distinct classes of gene targets, enabling them
to play distinct roles in the regulation of cell cycle pro-
gression (11). In addition, whereas pRb interacts predom-
inantly with E2F1, E2F2, and E2F3, p130 and p107 interact
primarily with E2F4 and E2F5 (9). Further, the associa-
tions between individual pocket proteins and their cognate
E2F partners occur at distinct times throughout the cell
cycle, reﬂecting, in part, differences in the temporal ex-
pression of each pocket protein throughout the cell cycle
(9).
A role for pocket proteins in regulating the -cell cycle
was ﬁrst suggested in 1985 by the observation that trans-
genic mice that express SV40 large T-antigen in the -cell
(RIP-TAg mice) develop hyperinsulinemia, hypoglycemia,
and ultimately islet tumors (12). Large T-antigen binds to
and inactivates pRb, p130, and p107 as well as other
cellular proteins (13). However, it remains uncertain from
these studies whether the increased -cell replication in
RIP-TAg mice resulted from inactivation of any one or
multiple pocket proteins or effects on other proteins
outside the pocket protein family.
The question as to which of the three pocket proteins is
sufﬁcient or necessary to restrict -cell cycle progression
has only recently begun to be investigated. We recently
reported that -cell–speciﬁc inactivation of the Rb gene
alone has surprisingly little effect on -cell replication,
function, and survival (14). However, it is possible, and
perhaps likely, that germline (i.e., chronic, life-long) inac-
tivation of Rb in -cells results in, or allows for, functional
compensation by one or both of the other pRb-related
members of the pocket protein family, p130 or p107.
Interestingly, although both p130 and p107 are known to
be present in murine pancreatic islets (15), their function
has never been evaluated in the -cell. To address this
question, we assessed -cell replication, function, and
glucose homeostasis in both p130
/ and p107
/ mice.
We also sought to address the possibility of functional
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of multiple pocket proteins (pRb and p130) in the -cell.
These studies reveal an essential and dramatic role for the
pocket protein family in the control of the -cell G1/S
transition.
RESEARCH DESIGN AND METHODS
Mouse models. Homozygous mutant mice with disrupted p107 (p107
/)o r
p130 (p130
/) genes were previously prepared and described by Cobrinik
and Lee (16,17). Both mutant genes function as null alleles (16,17). For
generation of Rb/p130 double mutants, mice in which exon 19 of the Rb1 gene
is ﬂanked by loxP recombination sites (Rb
lox/lox) (18) were crossed with
p130
/ animals. The resultant Rb
lox/;p130
/ mice were intercrossed to
generate Rb
lox/lox;p130
/ mice. Concurrently, RIP-Cre transgenic mice
(14,19) in which Cre expression is under the control of the rat insulin II
promoter (14) were crossed with p130
/ mice to generate RIP-Cre;p130
/
animals. Crossing the compound mutants generated Rb
lox/;p130
/;Cre
mice, which were backcrossed again to Rb
lox/lox;p130
/ mice to produce a
-cell conditional knockout (CKO) of Rb in p130
/ mutant mice (Rb
lox/lox;
p130
/;Cre referred to as Rb
CKO;p130
/). The breeding strategy is summa-
rized in additional detail in the Figures. Mice that were either wild type for Rb
(Rb
lox/lox or Rb
lox/; Cre-negative) or heterozygous (Rb
lox/; Cre-positive) on a
p130
/ background were also analyzed for comparison. All studies were
performed on adult mice, 2- to 4-months of age, on a mixed C57/BL6–129
genetic background, with males and females being comparably represented.
All studies were approved in advance by, and performed in compliance with,
the University of Pittsburgh Institutional Animal Care and Use Committee.
Islet isolation and culture. Islets were isolated from adult mice as previ-
ously described (14,15). Brieﬂy, islets were obtained from collagenase (Sigma,
St. Louis, MO) digested pancreases after puriﬁcation on a Histopaque (Sigma)
gradient.
Cell cycle analysis. To analyze cell cycle progression, islets were dis-
persed into single cells with 0.05% trypsin-EDTA (Invitrogen, Carlsbad,
CA), suspended in chilled 70% ethanol, and kept overnight at 4°C. Fixed
cells were treated with 100 units/ml RNAase A (Sigma) in PBS and stained
with 50 g/ml propidium iodide (Sigma) at room temperature for 30 min
(20). The cell cycle phase distribution of 10,000 cells was determined by
ﬂow cytometry using a BD LSR II ﬂow cytometer (Becton Dickinson
Biosciences, San Jose, CA). Analysis of data, including determination of
gates, was performed using Modﬁt LT 3.0 software (Verity Software House,
Topsham, ME) using gating shown in supplementary Figs. S1 and S4
(available in the online-only appendix at http://diabetes.diabetesjournals.
org/cgi/content/full/db08-0759/DC1).
Immunoblotting and PCR. Islet protein extractions were prepared as
previously described (14,15). Immunoblotting was performed using primary
antibodies for pRb (Pharmingen, 554136), p107 (Santa Cruz, C-18), p130
(Santa Cruz, C-17), p21 (Santa Cruz, F-5), p53 (Biomeda, V1003), phospho-p53
(Ser15) (Cell Signaling, 9286), Cre (Convance, MMS-106P), E2F1 (Santa Cruz,
C-20), and E2F2 (Santa Cruz, TFE-25) and secondary antisera as previously
published (14,15). Mice were genotyped by PCR using previously described
primers (14,16–18).
Glucose, insulin, and intraperitoneal glucose tolerance testing. Mea-
surements of fasting and postprandial blood glucose and plasma insulin levels,
as well as intraperitoneal glucose tolerance testing were performed as
detailed previously (14,15).
-cell mass, replication, and apoptosis. Six hours before being killed, mice
were injected intraperitoneally with bromodeoxyuridine (BrdU; Sigma) (50
mg/kg body wt). Pancreata were ﬁxed in Bouin’s solution, embedded in
parafﬁn, sectioned, and stained with insulin (Dako), BrdU (Abcam, Ab6326),
Ki-67 (Neomarkers, SP6), or phosphohistone H3 (Millipore, 06-570) antibodies
as previously described (14,15,20). For determination of -cell death, pancreas
sections were stained using the in situ cell death detection kit (Roche
Diagnostics, Indianapolis, IN) for identiﬁcation of transferase-mediated dUTP
nick-end labeling (TUNEL) and insulin double-positive cells (20).
Adenoviral infection. Islets isolated from wild-type (Rb
/;p130
/),
Rb
lox/lox;p130
/, and Rb
lox/lox;p130
/ mice were dispersed into single cells
with 0.05% trypsin-EDTA and transduced with a replication-deﬁcient recom-
binant adenovirus that expresses green ﬂuorescent protein (Ad.GFP) or Cre
recombinase (Ad.Cre) (a gift from Dr. Chris Newgard). Cells were transduced
at a multiplicity of infection of 200 for2ha t37°C, plated on coverslips, and
studied 72 h later. BrdU (1:1,000, Amersham) was added for the ﬁnal 24 h of
culture. Whole islets were also transduced and cultured for 72 h then frozen
for immublot or PCR analysis.
Statistical analysis. All data are presented as means  SE. Comparisons of
multiple means were performed using ANOVA with SPSS 16.0 statistical
software (Chicago, IL). P  0.05 was considered signiﬁcant.
RESULTS
The pRb homologs p130 and p107 are dispensable for
adult mouse -cell function and mass. Mice with inac-
tivating mutations in p130 or p107 have previously been
developed and characterized (16,17). These mice develop
normally, are fertile, and apart from modest skeletal
changes in p107 mutants, exhibit no obvious adult pheno-
types. However, these previous studies did not include any
assessment of  function or glucose homeostasis. The
gene-targeting strategies used to disrupt the p130 or p107
genes (16,17) are shown in Fig. 1A and supplementary Fig.
S1A (available in the online-only appendix). Mutant mice
were identiﬁed by PCR analysis of genomic DNA and
conﬁrmed as nulls by immoblotting for p130 or p107 in
isolated islets (Fig. 1B; supplementary Fig. S1B, avail-
able in the online-only appendix). Metabolic analysis
of adult p130-o rp107-deﬁcient mice revealed a com-
pletely normal phenotype, similar to that seen in mice
with Rb-null islets. Speciﬁcally, body weight, fasting and
postprandial blood glucose, and plasma insulin values
were entirely normal compared with heterozygous and
wild-type littermates (Fig. 1C–F; supplementary Fig.
S1C–F, available in the online-only appendix). Glucose
tolerance was also normal in mice lacking p130 or
p107, compared with wild-type littermates (Fig. 1D;
supplementary Fig. S1D, available in the online-only
appendix).
Consistent with normal glucose tolerance in the mu-
tants, pancreas and -cell mass were also normal in both
p130- and p107-null animals (Fig. 2A; supplementary Fig.
S2A, available in the online-only appendix). Histomorpho-
metric analysis of whole pancreas sections immuno-
stained for insulin revealed that, as with pRb (14), p130
and p107 are also entirely dispensable for normal pancreas
and -cell growth (Fig. 2B; supplementary Fig. S2B, avail-
able in the online-only appendix).
In vivo loss of p130 or p107 does not affect -cell
cycle control. Like pRb, p130 and p107 also regulate cell
cycle progression (9). Adult differentiated -cells that have
exited the cell cycle and entered a state of quiescence
express both p130 and p107 (Fig. 3B) (14,20). Therefore,
we speculated that loss of p130 or p107 in -cells might
result in aberrant cell cycle reentry. Instead, loss of either
p130 or p107 failed to affect -cell replication rates (Fig.
3A; supplementary Fig. S4A, available in the online-only
appendix) and islet cell cycle phase distribution (supple-
mentary Figs. S1 and S4B, available in the online-only
appendix). This may result from functional compensation
within the retinoblastoma family because there was a
striking upregulation of p107 protein in p130-null islets
(82.4  4.0%) (Fig. 3B). These ﬁndings demonstrate that
p130 and p107 are individually dispensable for maintaining
-cell cycle arrest in adult mouse -cells.
pRb and p130 cooperatively regulate the adult -cell
G1/S transition in vivo. The preceding data suggest that
in the absence of an individual pocket protein, functional
redundancy among the remaining members may be sufﬁ-
cient to maintain cell cycle arrest in -cells. Therefore, we
generated mutant mice in which -cells were deﬁcient for
both pRb as well as p130. Inactivation of both the Rb and
p130 genes was selected because disruption of both p130
and p107 is embryonic lethal (17) and because a previous
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/p130
/ mutant
mice developed an insulinoma, an effect not observed in
Rb
/p107
/ mutant mice (21). To disrupt both Rb and
p130 simultaneously, -cell–speciﬁc pRb CKO (Rb
CKO)
mice (Fig. 4A) (14) were crossed with p130-null mice to
generate compound Rb
CKO;p130
/ double-knockout mu-
tant mice (Fig. 4B). In addition, mice that were wild type
or heterozygous for Rb on a p130
/ background (Rb
WT;
p130
/ and Rb
HT;p130
/, respectively) were also ana-
lyzed for comparison. PCR analysis of genomic DNA was
used for identiﬁcation of double-mutant animals based
on the presence of ﬂoxed Rb alleles (283-bp), the Cre
transgene, and the 320-bp mutant p130 gene (Fig. 4C).
Immunoblot analysis of pRb and p130 revealed only
faint residual levels of pRb, likely reﬂecting expression
of pRb in the few non–-cells of isolated islets (ﬁbro-
blasts, -cells, endothelial cells, etc.) and absent p130
protein in extracts of isolated Rb
CKO;p130
/ islets
(Fig. 4D).
The percentage of replicating -cells was determined by
immunoﬂuorescent staining of Rb
WT;p130
/ and Rb
CKO;
p130
/ pancreatic sections for both insulin and Ki67.
Loss of both pRb and p130 resulted in an 11-fold increase
in the percentage of -cells expressing Ki67 compared
with control -cells (3.2  0.6% in Rb
CKO;p130
/ vs. 0.3 
0.1 in Rb
WT;p130
/,P 0.05) (Fig. 5A). -Cell entry into
S phase (BrdU
) also increased dramatically (14-fold) in
the absence of both pRb and p130 (3.8  0.7% in Rb
CKO;
p130
/ vs. 0.3  0.1% in Rb
WT;p130
/,P 0.004) (Fig.
5B). Finally, there was a 30-fold increase in the number of
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1854 DIABETES, VOL. 58, AUGUST 2009-cells entering mitosis as assessed using phosphorylation
of histone H3 (PHH3) on serine 10 (Fig. 5C).
To determine if increased -cell death was associated
with the accelerated cell division seen in Rb/p130 double-
mutant -cells, we examined apoptotic -cell death (Fig.
5D). In contrast to the very low number of apoptotic
-cells in control pancreata (0.05  0.04%), -cell death
was strikingly increased in Rb/p130-deﬁcient -cells
A
B
p130+/+ p130+/- p130-/-
0
50
100
150
200
250
300
350
P
a
n
c
r
e
a
s
 
w
e
i
g
h
t
 
(
m
g
)
p130+/+
p=ns
0.0
0.5
1.0
1.5
2.0
B
e
t
a
 
c
e
l
l
 
m
a
s
s
 
(
m
g
)
p=ns
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
B
e
t
a
 
c
e
l
l
 
a
r
e
a
 
p
e
r
p
a
n
c
r
e
a
s
 
a
r
e
a
 
(
%
)
p=ns
p130+/- p130-/- p130+/+ p130+/- p130-/- p130+/+ p130+/- p130-/-
FIG. 2. Islet histomorphometry in p130-null mice. A: Representative insulin-stained sections of whole pancreata and quantiﬁcation (B)o f-cell
mass and area based on pancreas mass that were not signiﬁcantly different in the three groups. WT (n  9), HT (n  5), and KO (n  7). (A
high-quality digital representation of this ﬁgure is available in the online issue.)
A B
IB: p107
WT        p130 KO WT       p107 KO
IB: p130
IB: pRb
/
Tubulin
WT      RbCKO
RbCKO mice1 p107 mice p130 mice
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
p130+/+ p130+/- p130-/-
p=ns
p130-/-
I
n
s
u
l
i
n
/
B
r
d
U
%
 
B
r
d
U
+
b
e
t
a
 
c
e
l
l
s
 
FIG. 3. -cell replication in p130-null islets and compensatory upregulation of pocket protein family members. A: Quantiﬁcation of -cell
replication (%BrdU
-insulin
 cells). Replication was not signiﬁcantly increased in p130-deﬁcient -cells (n  5) compared with WT (n  9) or
HT (n  5) mice. B: Representative immunoblots of Rb
CKO, p107,o rp130 WT or KO islet protein extracts probed for pRb, p107, and p130. Note
that the data for Rb
CKO mice have been previously published by Vasavada et al. (14) and are included for comparison of the data on p107 and p130.
(A high-quality digital representation of this ﬁgure is available in the online issue.)
G. HARB AND ASSOCIATES
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mechanism underlying the increased -cell apoptosis ap-
pears to involve a p53-dependent pathway because phos-
phorylation of p53 protein was increased in Rb
CKO;
p130
/ -cells, as was protein expression of the p53
target gene, p21
CIP1 (Fig. 5E).
Pancreas and -cell mass are signiﬁcantly reduced in
Rb
CKO;p130
/ mutant mice. In contrast to mice that
lack pRB, p130, or p107 individually in their -cells, adult
double-mutant mice had signiﬁcantly smaller pancreata
than controls (P  0.001; Fig. 6B). This almost 50%
reduction in pancreas mass remained signiﬁcant even
when adjusted for the approximate 20% reduction in body
weight (P  0.05; Fig. 6A and B, Fig. 7A). However,
exocrine cell proliferation (BrdU
) was not altered in
Rb
CKO;p130
/ animals compared with controls (0.03 
0.05% vs. 0.04  0.04%, n  3, P  ns). In addition, there
was no change in exocrine cell death (TUNEL
)i nRb
CKO;
p130
/ pancreata compared with control pancreata
(0.01  0.01% vs. 0.01  0.02%, n  3, P  ns). The reduction
in pancreas mass was accompanied by a signiﬁcant reduc-
tion in -cell mass, even when adjusted for body mass (Fig.
6C; P  0.04 vs. Rb
WT;p130
/). However, the ratio of -cell
area to total pancreas area was not reduced in double
mutants, suggesting a proportional reduction in both exo-
crine and endocrine pancreatic mass (Fig. 6C).
Rb
CKO;p130
/ mutant mice are only mildly metabol-
ically abnormal despite increased -cell turnover.
Intraperitoneal glucose tolerance tests revealed that dou-
ble mutants respond to a glucose challenge as efﬁciently as
controls (Fig. 7B). However, random sampling of post-
prandial blood glucose levels revealed Rb
CKO;p130
/
mice were mildly hyperglycemic (P  0.05) compared with
controls, whereas fasting blood glucose levels were simi-
lar (Fig. 7C). The postprandial hyperglycemia occurred
despite normal levels of circulating plasma insulin in
Rb
CKO;p130
/ mice (Fig. 7D). Thus, despite a statistically
signiﬁcant reduction in -cell mass, the slightly dwarfed
Rb
CKO;p130
/ mice contained a body weight–adjusted
-cell mass and function that allows them to maintain
near-normal glucose homeostasis largely in the normal
range.
Ex vivo deletion of pRb in p130
/ -cells also causes
increased proliferation. Off-target expression of the RIP
promoter in the CNS is well described and conceivably
might account for an islet phenotype. Thus, to determine
whether the increase in -cell proliferation in the double-
mutant mice resulted from direct (-cell) or indirect (CNS)
effects of pRb/p130 loss, we disrupted the Rb gene ex vivo
in both wild-type and p130
/ -cells using the Cre-LoxP
method of gene recombination. Isolated -cells from Rb
lox/
lox;p130
/ or Rb
lox/lox;p130
/ animals were transduced
with an adenovirus expressing Cre recombinase (Ad.Cre).
Expression of Cre in -cell nuclei could be detected within
24 h after infection (Fig. 8A). This resulted in efﬁcient
deletion of exon 19 at 72 h after transduction (Fig. 8B).
Cre-mediated deletion of pRb resulted in a reduction in
pRb protein levels, associated with an increase in both
p130 and p107 in Rb
lox/lox;p130
/ islets (Fig. 8C). Rb
lox/
lox;p130
/ islets displayed upregulated p107 expression.
This was further increased after deletion of pRb. Loss of
both pRb and p130 resulted in elevated E2F2, but not
E2F1, as assessed by immunoblot.
Most importantly, in agreement with the results ob-
tained from pRb/p130 mutant mice in vivo, disruption of
both pRb and p130 in -cells ex vivo also caused a striking
RIP-Cre RbCKO
RbCKO;p130-/-
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Ex19
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FIG. 4. Simultaneous inactivation of Rb and p130 genes in double-mutant mice. A: Generation of -cell–speciﬁc pRb conditional knockout mice
(Rb
CKO) has been previously described by our group (14). Mice that contain loxP sequences surrounding exon 19 of the RB gene were crossed
with RIP-Cre mice resulting in excision of the ﬂanked region (18) B: The Rb
CKO mice were crossed with p130
/ mice to obtain Rb
CKO;p130
/
double-mutant mice. C: PCR analysis of the Rb 283-bp product represents the ﬂoxed allele whereas the 235-bp allele represents the wild-type Rb
gene. The 320-bp product represents mutant p130. The lower panel indicates uniform ampliﬁcation of the Gapdh housekeeping standard and the
Cre transgene. D: Immunoblot analysis of pRb and p130 protein in isolated pancreatic islets reveals deﬁciency of the two proteins in
Rb
CKO;p130
/ double-mutant animals.
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vs. 1.6  1.3% Ad.GFP, P  0.05) (Fig. 8D and E). Ad.Cre
transduction of wild-type or Rb
/;p130
/ islets had no
effect on replication (Fig. 8D and E).
DISCUSSION
This study demonstrates that individual inactivation of the
pRb homologs, p130 or p107, like pRb itself (14), is
insufﬁcient to cause abnormal -cell cycle progression or
impair the function of these cells in vivo. In contrast, we
observe that simultaneous loss of two pocket proteins
(pRb and p130) in the pancreatic -cell results in strikingly
increased rates of -cell replication. This cell cycle accel-
eration is also accompanied by increased apoptosis in
-cells. Genetic disruption of multiple genes encoding cell
cycle regulators in mice has demonstrated key roles for
several proteins upstream of the pRb family (22,23). The
ﬁnal common pathway for enforcing cell cycle arrest has
traditionally been believed to be pRb. Thus, it was surpris-
ing to learn that disruption of the Rb gene in the pancreatic
-cell is not sufﬁcient to cause cell cycle progression (14).
Based on these unanticipated ﬁndings, we sought to
FIG. 5. Cell cycle progression and apoptosis in Rb/p130 double-deﬁcient -cells. Pancreatic sections from Rb
WT;p130
/ and Rb
CKO;p130
/
animals are shown ﬂuorescently stained for insulin (green) and (A) Ki67 (red), (B) BrdU (red), or (C) PHH3 (red). Quantitative analysis of the
percentage of double-positive -cells is in the right column for each proliferative marker (A–C). Rb
WT;p130
/ (n  5), Rb
HT;p130
/ (n  4),
Rb
CKO;p130
/ (n  5). *P < 0.05 compared with Rb
WT;p130
/ and Rb
HT;p130
/ (400 magniﬁcation) D: -cell apoptosis detection in
Rb
WT;p130
/,R b
HT;p130
/, and Rb
CKO;p130
/ pancreata by insulin-TUNEL colabeling and quantiﬁcation. *P < 0.05 compared with
Rb
WT;p130
/ and Rb
HT;p130
/. E: Representative immunoblots for phospho-p53, p53, and p21 in islets from Rb
WT;p130
/ or Rb
CKO;
p130
/ animals. Each blot was performed 3–5 times. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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or p107, might play a regulatory role in -cell proliferation.
Interestingly, like mice with pRb-null islets, adult p130
/
or p107
/ mice also displayed normal glucose homeosta-
sis as well as quantitative -cell histomorphometry and
replication rates. From these studies, it appeared that
individual pocket proteins are entirely dispensable for
maintaining -cell cycle arrest, or that the individual loss
of pRb, p130, or p107 is functionally compensated by
another pocket protein family member. These ﬁndings are
consistent with broad compensation among the pocket
protein family members (3,9,10).
Studies on mice lacking individual pocket proteins may
fail to highlight the signiﬁcance of any one particular
family member because of complementary and overlap-
ping roles. Perhaps the best example of this is the Rb-null
mouse that does not develop retinoblastoma unless either
p130 or p107 are also removed (21). In this study, we
found an upregulation of p107 protein in p130-null islets
(Fig. 3B and 8C), which has also been observed in other
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FIG. 6. Islet histomorphometry in Rb/p130 double-mutant mice. A: Representative insulin-stained sections of whole pancreata from Rb
WT;p130
/
(n  9), Rb
HT;p130
/ (n  5), and Rb
CKO;p130
/ (n  9) animals. B: Shows quantiﬁcation of pancreas mass as well as the pancreas-to-body
weight ratio that were signiﬁcantly reduced in Rb
CKO;p130
/ mice (*P < 0.05). C: Shows a signiﬁcant reduction in -cell mass, also when adjusted
for body weight (*P  0.04 vs. Rb
WT;p130
/). -cell area per pancreas area was similar in all three groups. (A high-quality digital representation
of this ﬁgure is available in the online issue.)
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1858 DIABETES, VOL. 58, AUGUST 2009Rb- (1,24) or p130-null (21,25) cell types. Increased levels
of p107 have also been demonstrated to be responsible for
enforcing cell cycle arrest in Rb-null MEFs because down-
regulation of p107 expression by siRNA molecules re-
sulted in increased proliferation (24). Therefore, we
speculated that in our model of unperturbed normal -cell
growth, individual or single loss of pRb, p130, or p107 may
be compensated for by the redundant antiproliferative
effects of the other two pocket proteins. Interestingly, in
islets from p107
/ mice, neither pRb or p130 levels were
upregulated. Instead, we observed reduced levels of pRb
in isolated p107
/ islets that has also been observed in
p107
/ adult adipocyte precursors (26). The authors of
that report implicated a role for the differing levels of pRb
and p107 in preadipocyte differentiation. However, what
role these proteins play in -cell differentiation from
their progenitors is unknown and warrants further
investigation.
Several lines of evidence have suggested that overlap-
ping functional roles for pocket proteins can be revealed
when mice combinatorially lack multiple pocket protein
members (25–29). Double-mutant mice with tissue-speciﬁc
Rb/p130 or Rb/p107 inactivation have helped uncover
redundancy among family members in speciﬁc cell types
such as keratinocytes (27), cardiac myocytes (28), intesti-
nal epithelial cells (29), and others. In fact, some tissues
display more aggressive phenotypes depending on which
combination of pocket proteins is inactivated. For exam-
ple, intestinal epithelial cells revealed a signiﬁcantly more
robust phenotype in Rb/p130 deﬁcient animals than in
Rb/p107 double-mutant animals (29). Further, studies
from doubly deﬁcient Rb/p130 and Rb/p107 mice re-
vealed that the tumor spectrum in these mice does not
entirely overlap (21). This is apparently true for the
pancreatic -cell as well because insulinomas arose
only in Rb
/p130
/ but not Rb
/p107
/ mice (21).
Indeed, we found signiﬁcantly elevated levels of -cell
replication were present in adult mice when both Rb and
p130 genes were fully inactivated.
Increases in cell cycle progression were observed using
three different markers of replication (BrdU, Ki67, PHH3).
Further, mutant -cells were also capable of progressing
into the late G2–early mitotic phase of the cell cycle as
assessed using PHH3. The increase in -cell proliferation
was accompanied by parallel increases in the rate of cell
death. This increase in cell death appeared to reﬂect
activation of the p53 pathway because active phospho-
p53 was elevated and because p21, downstream of p53,
was also elevated. In agreement with these results,
combined inactivation of p53 and Rb (p53
/Rb
/ and
p53
/Rb
/) was found to be sufﬁcient for the develop-
ment of insulinomas (30,31). The widespread apoptosis
detected in pRb/p130-deﬁcient -cells has not been ob-
served in other cell types deﬁcient in pRb and p130 such as
the myocardium (28) or intestinal epithelium (29).
Whether loss of both pRb and p107 in the -cell would
similarly increase both cell cycle entry and apoptosis is in
need of investigation. Studying -cells deﬁcient in all three
pocket proteins will be required to reveal the collective
role played by these proteins in regulating -cell cycle
A
C D
B
*
p<0.05
p=0.001
0
5
10
15
20
25
30
35
B
o
d
y
 
W
e
i
g
h
t
 
(
g
)
0
50
100
150
200
250
300
350
01 5 3 0 6 0 1 2 0
Time (mins)
B
l
o
o
d
 
G
l
u
c
o
s
e
 
(
m
g
/
d
l
)
0
20
40
60
80
100
120
140
160
180
200
B
l
o
o
d
 
G
l
u
c
o
s
e
 
(
m
g
/
d
l
)
g
Postprandial
RbWT;
p130-/-
RbHT;
p130-/-
RbCKO;
p130-/-
p=ns
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
I
n
s
u
l
i
n
 
(
n
g
/
m
l
) Postprandial
p=ns
RbWT;
p130-/-
RbHT;
p130-/-
RbCKO;
p130-/-
RbWT;
p130-/-
RbHT;
p130-/-
RbCKO;
p130-/- RbWT;
p130-/-
RbHT;
p130-/-
RbCKO;
p130-/-
*
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p130 and p107 in mice results in neonatal lethality (17), so
inactivation of all three members will require the genera-
tion of a triple–conditionally null mouse.
Pancreatic histology in the double-mutant mice, both
endocrine and exocrine, was interesting. In the endocrine
compartment, the -cell mass was reduced as compared
with body weight, presumably reﬂecting a mismatch in the
rates of -cell replication and cell death. In the exocrine
compartment, total pancreas weight was also decreased
(Fig. 6B), and this was disproportionate to the decline in
body weight (Fig. 7A). The reasons for the decline in body
weight and pancreatic weight are unclear, but both con-
trasted to liver, spleen, and kidney weights, which were
comparable in all three groups of animals (supplementary
Fig. S4, available in the online-only appendix). Pancreatic
acinar cell proliferation and apoptosis rates were normal.
We speculate that the decline in body weight may have
resulted from development of pituitary or hypothalamic
tumors, which are known to occur with pRb loss (32).
This may well have occurred in our double-mutant mice,
which were globally deﬁcient for p130 and may have been
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available in the online issue.)
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“leaky” expression of RIP-Cre (14,33,34).
These considerations raise the possibility that the
marked increases in -cell replication and cell death
might also have resulted from CNS misexpression of
RIP-Cre. Thus, we performed ex vivo studies in isolated
islets using adenoviral delivery of Cre recombinase (24).
These studies revealed that combined pRb and p130 loss
directly in -cells led to markedly increased -cell
replication. In agreement with our previously published
report on in vivo pRb deletion in -cells (14), we again
observed no increase in proliferation after in vitro
deletion of pRb alone. However, unlike the in vivo
studies, we did observe a compensatory increase in both
p130 and p107 levels after acute pRb ablation. On the
other hand, when pRb was reduced in -cells already
deﬁcient for p130, we observed a dramatic increase in
-cell proliferation. The increased proliferation was
associated with elevated E2F2 but not E2F1 levels. E2F2
is a member of the transcriptional activator E2Fs and
has been shown, along with E2F1, to play an essential
role in postnatal pancreas development (35,36).
In conclusion, this study demonstrates that both Rb and
p130 in combination are essential for normal pancreatic
-cell cycle control. Elucidation of therapeutic approaches
that permit the stimulation of -cell replication without
induction of apoptosis may provide an approach to expand
-cells for the treatment of diabetes.
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